Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gordon Thomas Honeywell (GTH) is a prominent legal and governmental affairs firm with a specialized global practice in forensic DNA policy and project development. Founded in 1894 and headquartered in Washington State, the firm's GTH-DNA division is a world leader in advising governments, law enforcement agencies, and international organizations on the implementation of forensic DNA databases and related legislation. GTH provides expert consultancy on the legal and technical frameworks required for effective forensic DNA programs across more than 50 countries. The firm also manages the Forensic DNA World Map Project and the annual DNA Hit of the Year program to highlight the impact of DNA technology in solving crimes and identifying missing persons. Beyond its forensic practice, GTH offers comprehensive lobbying and strategic advocacy services, bridging the gap between life science technologies and public policy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gordon Thomas Honeywell.